Form 8-K - Current report:
SEC Accession No. 0001437749-22-002038
Filing Date
2022-02-01
Accepted
2022-02-01 06:30:33
Documents
15
Period of Report
2022-02-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tech20220131_8k.htm   iXBRL 8-K 35597
2 EXHIBIT 99.1 ex_330131.htm EX-99.1 339590
3 EXHIBIT 99.2 ex_330132.htm EX-99.2 6876
  Complete submission text file 0001437749-22-002038.txt   541299

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tech-20220201.xsd EX-101.SCH 3593
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tech-20220201_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tech-20220201_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tech-20220201_pre.xml EX-101.PRE 11584
9 EXTRACTED XBRL INSTANCE DOCUMENT tech20220131_8k_htm.xml XML 2552
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 22576824
SIC: 2836 Biological Products, (No Diagnostic Substances)